The Total Synthesis and Biological Investigations of Ambiguine Natural Products
Project Number5F31GM123603-02
Contact PI/Project LeaderJOHNSON, REBECCA
Awardee OrganizationUNIVERSITY OF CALIFORNIA BERKELEY
Description
Abstract Text
7. Project Summary/Abstract
The class of prenylated indole alkaloids known as the ambiguines represents a
structurally intriguing class of compounds with interesting biological activity including
promising antibiotic and anti-fungal properties. Ambiguine E is arguably the most potent
of these natural products with a minimum inhibitory concentration (MIC) against
Staphylococcus aureus comparable to that of the FDA approved antibiotic gentamicin
(1.5 and 1.4 μg/mL respectively). Perhaps a more fascinating feature of these natural
products is their biosynthesis, which is suggested to involve the class of non-heme C–H
functionalizing enzymes known as the Rieske-oxygenases. It has been proposed that
these enzymes are responsible for the final oxidative diversification among the
ambiguines including cyclization, epoxidation, and dihydroxylation. In addition, a novel
class of non-heme C–H chlorinating enzymes have been identified as responsible for a
late-stage stereoselective sp3 chlorination leading to the chlorine-containing ambiguine
natural products. While a synthesis of tetracyclic (+)-ambiguine H was recently reported
by Baran and coworkers, a synthesis of any of the pentacyclic ambiguines has not yet
been accomplished. We envision that a divergent total synthesis of these densely
functionalized indole alkaloids will help elucidate mechanisms for the final Rieske
mediated oxidations in addition to exploring the promiscuity of the C–H chlorinating
enzymes. In light of this goal, we have completed a synthesis of the pentacyclic core of
the ambiguines utilizing a novel strategy in a four-step sequence. The completion of the
natural products and subsequent biosynthetic studies are proposed here.
Public Health Relevance Statement
8. Project Narrative
The synthesis of natural products and subsequent studies on their biosynthesis is
vital to providing a foundation for the development of novel pharmaceuticals including
antibiotics. While the ambiguine class of natural products are promising antibiotics,
perhaps even more intriguing is their biosynthesis which involves C–H chlorinating
enzymes and C–H activating enzymes known as the Rieske oxygenases. Completion of
the synthesis of a common intermediate would allow access to a wide variety of
pentacyclic ambiguine natural products and will be used to uncover fascinating aspects
of their biosynthesis that should lead to the identification of novel and important
bioactivity.
No Sub Projects information available for 5F31GM123603-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5F31GM123603-02
Patents
No Patents information available for 5F31GM123603-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5F31GM123603-02
Clinical Studies
No Clinical Studies information available for 5F31GM123603-02
News and More
Related News Releases
No news release information available for 5F31GM123603-02
History
No Historical information available for 5F31GM123603-02
Similar Projects
No Similar Projects information available for 5F31GM123603-02